| MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway S Mohammadi-Yeganeh, M Paryan, E Arefian, M Vasei, H Ghanbarian, ... Tumor Biology 37, 8993-9000, 2016 | 105 | 2016 |
| Development of a robust, low cost stem-loop real-time quantification PCR technique for miRNA expression analysis S Mohammadi-Yeganeh, M Paryan, S Mirab Samiee, M Soleimani, ... Molecular biology reports 40, 3665-3674, 2013 | 104 | 2013 |
| The role of microRNAs in different types of thyroid carcinoma: a comprehensive analysis to find new miRNA supplementary therapies S Pishkari, M Paryan, M Hashemi, E Baldini, S Mohammadi-Yeganeh Journal of endocrinological investigation 41, 269-283, 2018 | 76 | 2018 |
| Evaluation of exosomal miR‐9 and miR‐155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells V Kia, M Paryan, Y Mortazavi, A Biglari, S Mohammadi‐Yeganeh Journal of cellular biochemistry 120 (4), 5666-5676, 2019 | 73 | 2019 |
| Targeting of miR9/NOTCH1 interaction reduces metastatic behavior in triple‐negative breast cancer S Mohammadi‐Yeganeh, A Mansouri, M Paryan Chemical biology & drug design 86 (5), 1185-1191, 2015 | 64 | 2015 |
| Simultaneous underexpression of let-7a-5p and let-7f-5p microRNAs in plasma and stool samples from early stage colorectal carcinoma: supplementary issue: biomarkers for colon … R Ghanbari, N Mosakhani, VK Sarhadi, G Armengol, N Nouraee, ... Biomarkers in cancer 7, BIC. S25252, 2015 | 60 | 2015 |
| WNT1 gene from WNT signaling pathway is a direct target of miR-122 in hepatocellular carcinoma Z Ahsani, S Mohammadi-Yeganeh, V Kia, H Karimkhanloo, N Zarghami, ... Applied biochemistry and biotechnology 181, 884-897, 2017 | 59 | 2017 |
| Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical … V Pourteimoor, S Mohammadi-Yeganeh, M Paryan Tumor Biology 37, 14479-14499, 2016 | 46 | 2016 |
| miR-141 as potential suppressor of β-catenin in breast cancer N Abedi, S Mohammadi-Yeganeh, A Koochaki, F Karami, M Paryan Tumor Biology 36, 9895-9901, 2015 | 45 | 2015 |
| Prevalence of multiple infections and the risk of gastric adenocarcinoma development at earlier age S Fattahi, N Nikbakhsh, H Taheri, E Ghadami, M Kosari-Monfared, ... Diagnostic microbiology and infectious disease 92 (1), 62-68, 2018 | 37 | 2018 |
| Design and development of a quantitative real time PCR assay for monitoring of HTLV-1 provirus in whole blood M Naderi, M Paryan, K Azadmanesh, H Rafatpanah, H Rezvan, ... Journal of clinical virology 53 (4), 302-307, 2012 | 32 | 2012 |
| Evaluation of miRNAs expression in medullary thyroid carcinoma tissue samples: miR-34a and miR-144 as promising overexpressed markers in MTC N Shabani, J Razaviyan, M Paryan, SM Tavangar, F Azizi, ... Human pathology 79, 212-221, 2018 | 30 | 2018 |
| Exosomal miRNAs from highly metastatic cells can induce metastasis in non-metastatic cells Y Mortazavi, M Paryan, A Biglari, S Mohammadi-Yeganeh Life sciences 220, 162-168, 2019 | 28 | 2019 |
| Bioinformatics Prediction and In Vitro Analysis Revealed That miR‐17 Targets Cyclin D1 mRNA in Triple Negative Breast Cancer Cells F Karami, S Mohammadi‐Yeganeh, N Abedi, A Koochaki, V Kia, ... Chemical Biology & Drug Design 87 (3), 317-320, 2016 | 26 | 2016 |
| Investigation of deregulated genes of Notch signaling pathway in human T cell acute lymphoblastic leukemia cell lines and clinical samples M Paryan, S Mohammadi-Yeganeh, SM Samiee, M Soleimani, E Arefian, ... Molecular biology reports 40, 5531-5540, 2013 | 26 | 2013 |
| An investigation on the expression of miRNAs including miR‐144 and miR‐34a in plasma samples of RET‐positive and RET‐negative medullar thyroid carcinoma … N Shabani, S Sheikholeslami, M Paryan, M Zarif Yeganeh, SM Tavangar, ... Journal of Cellular Physiology 235 (2), 1366-1373, 2020 | 25 | 2020 |
| The effect of miR‐340 over‐expression on cell‐cycle–related genes in triple‐negative breast cancer cells S Mohammadi Yeganeh, M Vasei, R Tavakoli, V Kia, M Paryan European journal of cancer care 26 (6), e12496, 2017 | 25 | 2017 |
| Quantitation of human cytomegalovirus DNA in plasma using an affordable in-house qPCR assay B Khansarinejad, H Soleimanjahi, SM Samiee, AA Hamidieh, M Paryan, ... Journal of virological methods 183 (2), 170-175, 2012 | 25 | 2012 |
| Bioinformatics prediction and experimental validation of microRNA-20a targeting Cyclin D1 in hepatocellular carcinoma H Karimkhanloo, S Mohammadi-Yeganeh, Z Ahsani, M Paryan Tumor Biology 39 (4), 1010428317698361, 2017 | 24 | 2017 |
| Wnt pathway targeting reduces triple‐negative breast cancer aggressiveness through miRNA regulation in vitro and in vivo S Mohammadi‐Yeganeh, V Hosseini, M Paryan Journal of Cellular Physiology 234 (10), 18317-18328, 2019 | 23 | 2019 |
